299 related articles for article (PubMed ID: 24379819)
1. Toward a Network Model of MHC Class II-Restricted Antigen Processing.
Miller MA; Ganesan AP; Eisenlohr LC
Front Immunol; 2013 Dec; 4():464. PubMed ID: 24379819
[TBL] [Abstract][Full Text] [Related]
2. Alternative generation of MHC class II-restricted epitopes: not so exceptional?
Eisenlohr LC
Mol Immunol; 2013 Sep; 55(2):169-71. PubMed ID: 23200635
[TBL] [Abstract][Full Text] [Related]
3. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.
Braciale TJ; Morrison LA; Sweetser MT; Sambrook J; Gething MJ; Braciale VL
Immunol Rev; 1987 Aug; 98():95-114. PubMed ID: 2443444
[TBL] [Abstract][Full Text] [Related]
4. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
[TBL] [Abstract][Full Text] [Related]
5. The Other Function: Class II-Restricted Antigen Presentation by B Cells.
Adler LN; Jiang W; Bhamidipati K; Millican M; Macaubas C; Hung SC; Mellins ED
Front Immunol; 2017; 8():319. PubMed ID: 28386257
[TBL] [Abstract][Full Text] [Related]
6. Alternative processing pathways for MHC class I-restricted epitope presentation to CD8+ cytotoxic T lymphocytes.
Reimann J; Böhm W; Schirmbeck R
Biol Chem Hoppe Seyler; 1994 Nov; 375(11):731-6. PubMed ID: 7535058
[TBL] [Abstract][Full Text] [Related]
7. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
[TBL] [Abstract][Full Text] [Related]
8. Antigen-B Cell Receptor Complexes Associate with Intracellular major histocompatibility complex (MHC) Class II Molecules.
Barroso M; Tucker H; Drake L; Nichol K; Drake JR
J Biol Chem; 2015 Nov; 290(45):27101-27112. PubMed ID: 26400081
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
10. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
11. Influenza A virus infection-induced macroautophagy facilitates MHC class II-restricted endogenous presentation of an immunodominant viral epitope.
Deng J; Lu C; Liu C; Oveissi S; Fairlie WD; Lee EF; Bilsel P; Puthalakath H; Chen W
FEBS J; 2021 May; 288(10):3164-3185. PubMed ID: 33830641
[TBL] [Abstract][Full Text] [Related]
12. MHC class II presentation of endogenous tumor antigen by cellular vaccines depends on the endocytic pathway but not H2-M.
Qi L; Ostrand-Rosenberg S
Traffic; 2000 Feb; 1(2):152-60. PubMed ID: 11208095
[TBL] [Abstract][Full Text] [Related]
13. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
14. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
15. Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells.
Bosch B; Berger AC; Khandelwal S; Heipertz EL; Scharf B; Santambrogio L; Roche PA
J Biol Chem; 2013 Aug; 288(34):24286-92. PubMed ID: 23846690
[TBL] [Abstract][Full Text] [Related]
16. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment.
Dani A; Chaudhry A; Mukherjee P; Rajagopal D; Bhatia S; George A; Bal V; Rath S; Mayor S
J Cell Sci; 2004 Aug; 117(Pt 18):4219-30. PubMed ID: 15316082
[TBL] [Abstract][Full Text] [Related]
17. Sequential proteolytic processing of the capsular Caf1 antigen of Yersinia pestis for major histocompatibility complex class II-restricted presentation to T lymphocytes.
Musson JA; Morton M; Walker N; Harper HM; McNeill HV; Williamson ED; Robinson JH
J Biol Chem; 2006 Sep; 281(36):26129-35. PubMed ID: 16840777
[TBL] [Abstract][Full Text] [Related]
18. Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.
Eisenlohr LC; Luckashenak N; Apcher S; Miller MA; Sinnathamby G
Immunol Res; 2011 Dec; 51(2-3):237-48. PubMed ID: 22101673
[TBL] [Abstract][Full Text] [Related]
19. Class II MHC molecules can use the endogenous pathway of antigen presentation.
Nuchtern JG; Biddison WE; Klausner RD
Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
